These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 16418506
1. Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer. Tuma RS. J Natl Cancer Inst; 2006 Jan 18; 98(2):86-7. PubMed ID: 16418506 [No Abstract] [Full Text] [Related]
6. Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors. Hargis JB, Nakajima ST. Cancer Invest; 2006 Mar 18; 24(2):174-7. PubMed ID: 16537187 [Abstract] [Full Text] [Related]
8. Anastrozole data show continued delay in relapse, but no clear survival advantage. Travis K. J Natl Cancer Inst; 2005 Jan 19; 97(2):86-7. PubMed ID: 15657334 [No Abstract] [Full Text] [Related]
16. A case of brain metastases from breast cancer that responded to anastrozole monotherapy. Ito K, Ito T, Okada T, Watanabe T, Gomi K, Kanai T, Mochizuki Y, Amano J. Breast J; 2009 Jan 19; 15(4):435-7. PubMed ID: 19470131 [No Abstract] [Full Text] [Related]
20. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A. J Clin Oncol; 2007 Feb 10; 25(5):486-92. PubMed ID: 17200148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]